美国国立糖尿病、消化和肾脏疾病研究所：庆祝推进糖尿病研究75周年。 - Suppr

Suppr

超能文献

NIDDK: Celebrating 75 Years of Advancing Diabetes Research.

作者信息

Cefalu William T, Cerio Rebecca J, Silva Corinne M, Wallace Julie A, Rodgers Griffin P

机构信息

National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD.

出版信息

Diabetes Care. 2025 Jul 1;48(7):1085-1088. doi: 10.2337/dci25-0044.

DOI:10.2337/dci25-0044

PMID:40272276

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12178610/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e889/12178610/28279e3ff056/dci250044f1.jpg

相似文献

NIDDK: Celebrating 75 Years of Advancing Diabetes Research.美国国立糖尿病、消化和肾脏疾病研究所：庆祝推进糖尿病研究75周年。

Diabetes Care. 2025 Jul 1;48(7):1085-1088. doi: 10.2337/dci25-0044.

NIDDK: Celebrating 75 Years of Advancing Diabetes Research.美国国立糖尿病、消化和肾脏疾病研究所：庆祝推进糖尿病研究75周年。

Diabetes. 2025 Jul 1;74(7):1053-1056. doi: 10.2337/dbi25-0023.

Celebrating the Past, Present, and Future of NIDDK-Supported Research Centers Focused on Diabetes, Endocrinology, and Metabolic Diseases.庆祝国立糖尿病、消化和肾脏疾病研究所（NIDDK）支持的专注于糖尿病、内分泌学和代谢性疾病的研究中心的过去、现在和未来。

Diabetes. 2025 Jul 1;74(7):1099-1106. doi: 10.2337/db25-0039.

Commentary: Parallel evolution of Molecular Endocrinology as a journal and a discipline: convergence of interests with the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK/NIH).评论：《分子内分泌学》作为一本期刊和一门学科的平行发展：与美国国立糖尿病、消化和肾脏疾病研究所（NIDDK/NIH）的兴趣趋同。

Mol Endocrinol. 2010 Sep;24(9):1697-702. doi: 10.1210/me.2010-0168. Epub 2010 Jul 21.

Closing the Gap Between Vision and Victory in Type 1 Diabetes: The NIDDK Human Islet Research Network (HIRN) Initiative.缩小1型糖尿病领域愿景与胜利之间的差距：美国国立糖尿病、消化和肾脏疾病研究所人类胰岛研究网络（HIRN）倡议

Diabetes. 2025 Jul 1;74(7):1057-1067. doi: 10.2337/db25-0097.

'What's in the NIDDK CDR?'--public query tools for the NIDDK central data repository.“NIDDK CDR 里有什么？”——NIDDK 中心数据存储库的公共查询工具。

Database (Oxford). 2013 Feb 8;2013:bas058. doi: 10.1093/database/bas058. Print 2013.

IL-6 receptor blockade does not slow β cell loss in new-onset type 1 diabetes.白介素-6 受体阻断剂不能减缓新诊断 1 型糖尿病患者的胰岛β细胞损失。

JCI Insight. 2021 Nov 8;6(21):e150074. doi: 10.1172/jci.insight.150074.

Unfolding the Mystery of Autoimmunity: The Environmental Determinants of Diabetes in the Young (TEDDY) Study.揭开自身免疫之谜：青少年糖尿病的环境决定因素（TEDDY）研究

Diabetes Care. 2025 Jul 1;48(7):1125-1135. doi: 10.2337/dc24-2886.

Accelerating Medicines Partnership in Type 2 Diabetes and Common Metabolic Diseases: Collaborating to Maximize the Value of Genetic and Genomic Data.2型糖尿病和常见代谢疾病加速药物合作组织：携手合作以最大化遗传和基因组数据的价值。

Diabetes. 2025 Jul 1;74(7):1089-1098. doi: 10.2337/db25-0042.

Reliability and validity of the NIDDK-QA instrument in the assessment of quality of life in ambulatory patients with cholestatic liver disease.美国国立糖尿病、消化和肾脏疾病研究所生活质量评估量表（NIDDK-QA）在评估胆汁淤积性肝病门诊患者生活质量中的信度和效度

Hepatology. 2000 Nov;32(5):924-9. doi: 10.1053/jhep.2000.19067.

本文引用的文献

Type 1 Diabetes TrialNet: Leading the Charge in Disease Prediction, Prevention, and Immunotherapeutic Mechanistic Understanding.1型糖尿病试验网：在疾病预测、预防及免疫治疗机制理解方面引领潮流。

Diabetes Care. 2025 Jul 1;48(7):1112-1124. doi: 10.2337/dc24-2908.

Youth-Onset Type 2 Diabetes: What We've Learned From Key Youth-Onset Type 2 Diabetes Studies, What We Still Don't Know, and Why It Is Important.青少年发病的2型糖尿病：我们从关键的青少年发病的2型糖尿病研究中学到了什么，我们仍然不知道什么，以及为什么它很重要。

Diabetes Care. 2025 Jul 1;48(7):1136-1149. doi: 10.2337/dc25-0001.

The Diabetes Prevention Program and Its Outcomes Study: NIDDK's Journey Into the Prevention of Type 2 Diabetes and Its Public Health Impact.糖尿病预防计划及其结果研究：美国国立糖尿病、消化和肾脏疾病研究所预防2型糖尿病的历程及其对公共卫生的影响。

Diabetes Care. 2025 Jul 1;48(7):1101-1111. doi: 10.2337/dc25-0014.

Unfolding the Mystery of Autoimmunity: The Environmental Determinants of Diabetes in the Young (TEDDY) Study.揭开自身免疫之谜：青少年糖尿病的环境决定因素（TEDDY）研究

Diabetes Care. 2025 Jul 1;48(7):1125-1135. doi: 10.2337/dc24-2886.

The NIDDK Takes on the Complications of Type 1 Diabetes: The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study.美国国立糖尿病、消化和肾脏疾病研究所应对1型糖尿病并发症：糖尿病控制与并发症试验/糖尿病干预与并发症流行病学（DCCT/EDIC）研究。

Diabetes Care. 2025 Jul 1;48(7):1089-1100. doi: 10.2337/dc24-2885.

Advances in Cell Replacement Therapies for Diabetes.糖尿病细胞替代疗法的进展

Diabetes. 2025 Apr 24. doi: 10.2337/db25-0037.

Diabetes. 2025 Jul 1;74(7):1057-1067. doi: 10.2337/db25-0097.

The Cardiovascular Repository for Type 1 Diabetes (CaRe-T1D): An NIDDK Initiative to Advance Understanding of Mechanisms Underlying Cardiovascular Disease in Type 1 Versus Type 2 Diabetes.1型糖尿病心血管疾病资料库（CaRe-T1D）：美国国立糖尿病、消化和肾脏疾病研究所推进对1型与2型糖尿病心血管疾病潜在机制理解的倡议。

Diabetes. 2025 Apr 24. doi: 10.2337/db25-0017.

Diabetes. 2025 Jul 1;74(7):1099-1106. doi: 10.2337/db25-0039.

A Research Roadmap to Address the Heterogeneity of Diabetes and Advance Precision Medicine.应对糖尿病异质性并推进精准医学的研究路线图。

J Clin Endocrinol Metab. 2025 Feb 18;110(3):601-610. doi: 10.1210/clinem/dgae844.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验